Global Pertussis Vaccine Consumption Market Research Report 2020 by Manufacturers, Regions, Types and Applications By Innovation Market Research, Inc

 Pulichser: XYZResearch

May 2020

 Pages: 104

 IMR 9734

In this report,the Pertussis Vaccine revenue had reached about 5147.12 million USD in 2016 from 4026.75 million USD in 2012 in global, with the CAGR of 6.33%. Pertussis vaccine is a vaccine that protects against whooping cough.

There are two main types: Whole-cell vaccines and Acellular vaccines. The whole-cell vaccine is about 78% effective while the Acellular vaccine is 71–85% effective. The sales proportion of Acellular vaccines in 2016 was about 92.6%. The Pertussis Vaccine can be used for Children and Adults. The most proportion of Pertussis Vaccine was adults, and the sales proportion was about 93.6% in 2016.

Key market participants covered in the report include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Astellas Pharma, Minhai Biotechnology, Wuhan Institute of Biological Products and Changchun Changsheng Life Sciences.

Asia-Pacific was the largest sales place, with revenue market share about 38.7% in 2016. Following Asia-Pacific, Europe was the second largest sales place with the revenue market share of nearly 31.3%. North America, Latin America and Middle East and Africa are also important sales regions for Pertussis Vaccine.

Geographically, global Pertussis Vaccine Consumption market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Sanofi Pasteur
Mitsubishi Tanabe Pharma
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Whole-cell vaccines
Acellular vaccines

For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Pertussis Vaccine Consumption for each application, including
Children Application
Adults Application

Production, consumption, revenue, market share and growth rate are the key targets for Pertussis Vaccine Consumption from 2014 to 2026 (forecast) in these regions
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!

  +91 810 895 3541